Jasper Therapeutics Inc

JSPRNASDAQ · USD
0.62USD0.00 (-2.58%)
112

Jasper Therapeutics Inc (JSPR) Option Chain

As of September 18, 2026, Jasper Therapeutics Inc is trading at $0.62, a -2.58% change from the previous close. The nearest expiration is Oct 16, 2026. Implied volatility is 420.5%. IV Rank is 65%.

Read more

Tracking the JSPR option chain helps you see every strike and expiry on Jasper Therapeutics Inc in one view, so you can quickly identify the contracts that fit your thesis and your risk. Jasper Therapeutics Inc's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of JSPR options activity at a glance. Use our scanner to monitor the JSPR option chain in real time and filter for the JSPR options trades that actually meet your criteria.

An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For JSPR stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the JSPR option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where JSPR stock options are being actively traded and where they are not.

Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for hematopoietic stem cell transplantation and gene therapies. It focuses on the development and commercialization of conditioning agents and stem cell engineering to allow expanded use of stem cell transplantation and ex vivo gene therapy, a technique in which genetic manipulation of cells is performed outside the body prior to transplantation. The company's lead product candidate is JSP191, which is in clinical development as a conditioning antibody that clears hematopoietic stem cells from bone marrow in patients prior to undergoing allogeneic stem cell therapy or stem cell gene therapy.

It is also developing engineered hematopoietic stem cells product candidates to overcome key limitations of allogeneic and autologous gene-edited stem cell grafts. The company is based in Redwood City, California.

Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls Jasper Therapeutics Inc's full chain across every expiry, highlights the most liquid strikes, and lets you screen JSPR options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of JSPR stock options — let the full option chain come to you, pre-filtered and ready to trade.

Stock Statistics

  • IndustryBiotechnology
  • SectorHealthcare
  • IV percentile66.27% Neutral
  • Market cap (M$)21
  • 52 weeks high-76.95%
  • 52 weeks low93.75%
  • Analyst recommendationStrong Buy
    1.00
  • Target price$9.00
    1351.61% above the current stock price
  • Dividend
  • Payout ratio
  • Earnings date2026-11-09
  • P/E
  • Future P/E
  • EPS (ttm)-1.58
  • EPS growth next 5 years39.61%

As of September 18, 2026

2026-10-16
5 strikes
Default
CALLsPUTs
Prob. OTM %Open InterestVolumeExtrinsic ValueIntrinsic ValueBidAskStrikeMoneyness %BidAskIntrinsic ValueExtrinsic ValueVolumeOpen InterestProb. OTM %
64.9544410.580.120.700.50-19.350.100.000.10011135.05
83.8435200.350.000.351.00+61.291.000.380.6206016.16
91.001701.000.001.001.50+141.940.501.500.880.120319.00
94.43301.000.001.002.00+222.580.951.951.380.07005.57
96.301101.000.001.002.50+303.231.452.451.880.07003.70

As of September 18, 2026

Scan the full option chain in one place

Browse the full JSPR option chain across every strike and expiration, filter by IV, volume, and open interest, and evaluate your trade without switching tools.

Start your 14-day free trial